<?xml version='1.0' encoding='utf-8'?>
<regulation prefix="Regulation" num=".14" citation="COMAR 10.07.09.14" title_num="10" subtitle_num="07" chapter_num="09" heading="Physical and Chemical Restraints.">
  <paragraph num="A.">
    <text>Physical restraints may be used only:</text>
    <paragraph num="(1)">
      <text>As an integral part of an individual medical treatment plan;</text>
    </paragraph>
    <paragraph num="(2)">
      <text>If absolutely necessary to protect the resident or others from injury;</text>
    </paragraph>
    <paragraph num="(3)">
      <text>If prescribed by a physician or administered by another health care professional practicing within the scope of their license; and</text>
    </paragraph>
    <paragraph num="(4)">
      <text>If less restrictive alternatives were considered and appropriately ruled out by the physician.</text>
    </paragraph>
  </paragraph>
  <paragraph num="B.">
    <text>Use of Physical Restraints.</text>
    <paragraph num="(1)">
      <text>When a facility uses physical restraints, personnel:</text>
      <paragraph num="(a)">
        <text>Trained in the use of restraints shall check a resident in restraint at least every 2 hours, and maintain a record of the checks and usage; and</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Shall provide opportunities for motion and exercise during each 2-hour period in which physical restraint is used, and shall monitor the use of the restraint use and maintain a record of it.</text>
      </paragraph>
    </paragraph>
    <paragraph num="(2)">
      <text>The attending physician shall ensure that treatment plans include provisions for the progressive elimination of physical restraints.</text>
    </paragraph>
  </paragraph>
  <paragraph num="C.">
    <text>Use of Psychopharmacologic Drugs. When a physician prescribes psychopharmacologic drugs for a resident, the resident's clinical records shall contain all of the following documentation:</text>
    <paragraph num="(1)">
      <text>A physician's indication that the dosage, duration, indication, and monitoring are clinically appropriate and the reasons why they are clinically appropriate;</text>
    </paragraph>
    <paragraph num="(2)">
      <text>Indication that the resident is being monitored for adverse complications of the drug therapy;</text>
    </paragraph>
    <paragraph num="(3)">
      <text>Confirmation that previous attempts at dosage reduction have been unsuccessful, if applicable;</text>
    </paragraph>
    <paragraph num="(4)">
      <text>Evidence of the resident's subjective or objective improvement, or maintenance or function, while taking the medication;</text>
    </paragraph>
    <paragraph num="(5)">
      <text>Evidence that the resident's decline or deterioration, if applicable, has been evaluated by the interdisciplinary team to determine whether a particular drug, a particular dosage, or duration of therapy may be the cause;</text>
    </paragraph>
    <paragraph num="(6)">
      <text>Evidence of why the resident's age, weight, or other factors would require a unique drug dose, drug duration, indication, or monitoring; or</text>
    </paragraph>
    <paragraph num="(7)">
      <text>Other evidence that substantiates the use of the restraint.</text>
    </paragraph>
  </paragraph>
</regulation>